Peptide Super-Agonist Enhances T-Cell Responses to Melanoma. (2019)
Attributed to:
Comprehensive analysis of T-cell receptor degeneracy and T-cell crossreactivity
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.00319
PubMed Identifier: 30930889
Publication URI: http://europepmc.org/abstract/MED/30930889
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in immunology
ISSN: 1664-3224